Boya Bio: Senior executive Chen Bing resigns

Boya Bio-Pharmaceutical Group (SZSE:300294) announced the resignation of Vice President Chen Bing, effective from May 7, 2025. According to the announcement, Chen's resignation is due to personal reasons, and he will no longer hold any position within the company. His resignation will not affect the company's normal operations. Chen held 71,300 shares of Boya Bio, accounting for 0.01% of the company's total share capital. The original term was set to expire on March 20, 2027. Following the resignation, Chen will comply with regulations regarding shareholding and trading by directors, supervisors, and senior management, including restrictions on stock sales. Boya Bio's board of directors expressed gratitude for Chen's contributions during his tenure.